U.S., July 17 -- ClinicalTrials.gov registry received information related to the study (NCT07067385) titled 'Personalized mRNA Cancer Vaccine for Gastrointestinal Solid Tumor Treatment' on June 24.
Brief Summary: Evaluating the efficacy and safety of Neoantigen Personalized Cancer Vaccine deepGeneAI-001 in combination with Sintilimab in the treatment of Gastrointestinal Solid Tumors
Study Start Date: July 01
Study Type: INTERVENTIONAL
Condition:
Personalized Neoantigen Vaccine in Combination With Anti-PD-1 Inhibitors in Standard Therapy-Failed and Adjuvant Therapy
Gastrointestinal Tumors
Intervention:
BIOLOGICAL: Neoantigen Personalized Cancer Vaccine
Cohort 1: subjects will receive neoantigen tumor vaccine combination with Sintilim...